Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Babsmoneyon Nov 21, 2018 2:04pm

105 Views

Post# 29005928

RE:NF is going to be a powerhouse company in the CBD space

The problem investors have is they don’t give specific numbers for pens selling out and drinks selling out. Did the sell a 6 pack in a store or hundreds of thousands? Makes a big difference! Personally I hope the sell millions of each. I guess only financials will tell but not 4th quarter we’re talking 1st quarter next year.

Bullboard Posts

Corus reports Q1 profit drop in the face of falling revenue